Clinical Trial

Evaluation of the Effects of Laughter Yoga

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 13, 2026 (before its estimated July 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized controlled study aims to evaluate the effects of laughter yoga on pain intensity, fatigue, and beta-endorphin levels in patients with Multiple Sclerosis. Laughter yoga, a complementary therapy combining breathing exercises and laughter techniques, may help improve symptom management and psychological well-being in individuals with MS.
Trial Details
NCT Number NCT07524231
Lead Sponsor Firat University
Conditions Multiple Sclerosis
Enrollment 72 participants
Start Date 2026-03-10
Primary Completion 2026-07-10 (estimated)
Study Completion 2026-08-10 (estimated)
Updated on ClinicalTrials.gov 2026-04-13